These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3285196)

  • 41. Comparison of in vivo and in vitro cytogenetic assay results.
    Thompson ED
    Environ Mutagen; 1986; 8(5):753-67. PubMed ID: 3769875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals.
    Ishidate M
    Mutat Res; 1988; 205(1-4):397-407. PubMed ID: 3367924
    [No Abstract]   [Full Text] [Related]  

  • 43. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal.
    Rosenkranz HS; Mermelstein R
    Mutat Res; 1983 Apr; 114(3):217-67. PubMed ID: 6300670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutagenicity screening with fungal systems.
    Zimmermann FK
    Ann N Y Acad Sci; 1983; 407():186-96. PubMed ID: 6349475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Yeast-based genotoxicity tests for assessing DNA alterations and DNA stress responses: a 40-year overview.
    Eki T
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2493-2507. PubMed ID: 29423630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication ('malsegregation') in the yeast Saccharomyces cerevisiae: relevance to human carcinogenesis and developmental toxicology.
    Liu M; Grant SG; Macina OT; Klopman G; Rosenkranz HS
    Mutat Res; 1997 Mar; 374(2):209-31. PubMed ID: 9100845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic activity of actinomycin D in Saccharomyces cerevisiae but not in Escherichia coli.
    Nestmann ER; Nasim A; Haynes RH; Kowbel DJ
    Mutat Res; 1981 Jul; 89(3):229-36. PubMed ID: 7022197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive exercise in comparative mutagenesis with exciting outcome or how good are mutation assays in predicting carcinogens?
    Sobels FH
    Mutat Res; 1985; 147(1-2):1-4. PubMed ID: 3919291
    [No Abstract]   [Full Text] [Related]  

  • 50. Comprehensive retrospective evaluation of existing in vitro chromosomal aberration test data by cytotoxicity index transformation.
    Fujita Y; Morita T; Matsumura S; Kawamoto T; Ito Y; Nishiyama N; Honda H
    Mutat Res Genet Toxicol Environ Mutagen; 2016 May; 802():38-49. PubMed ID: 27169375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recommendations for the performance of UDS tests in vitro and in vivo.
    Madle S; Dean SW; Andrae U; Brambilla G; Burlinson B; Doolittle DJ; Furihata C; Hertner T; McQueen CA; Mori H
    Mutat Res; 1994 Jun; 312(3):263-85. PubMed ID: 7514739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of BC, 4CMB and 4HMB upon the induction of mitotic gene conversion in yeast.
    Parry JM
    Mutat Res; 1982; 100(1-4):145-51. PubMed ID: 7035883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic activity in yeast assays of reputed nonmutagenic, carcinogenic N-nitroso compounds and methapyrilene hydrochloride.
    Mehta RD; von Borstel RC
    IARC Sci Publ; 1984; (57):721-9. PubMed ID: 6398305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects the BC, 4CMB and 4HMB upon the induction of mitotic gene conversion and mutation in yeast.
    Goodwin DE; Parry JM
    Mutat Res; 1982; 100(1-4):153-6. PubMed ID: 7035885
    [No Abstract]   [Full Text] [Related]  

  • 55. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome aberration assays in Pisum for the study of environmental mutagens.
    Grant WF; Owens ET
    Mutat Res; 2001 May; 488(2):93-118. PubMed ID: 11344039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity.
    Dearfield KL; Auletta AE; Cimino MC; Moore MM
    Mutat Res; 1991 Nov; 258(3):259-83. PubMed ID: 1719404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals.
    Gibson DP; Brauninger R; Shaffi HS; Kerckaert GA; LeBoeuf RA; Isfort RJ; Aardema MJ
    Mutat Res; 1997 Aug; 392(1-2):61-70. PubMed ID: 9269331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.